Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.
2.

Topiramate blocks perinatal hypoxia-induced seizures in rat pups.

Koh S, Jensen FE.

Ann Neurol. 2001 Sep;50(3):366-72.

PMID:
11558793
3.

Talampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.

Aujla PK, Fetell MR, Jensen FE.

Epilepsia. 2009 Apr;50(4):694-701. doi: 10.1111/j.1528-1167.2008.01947.x. Epub 2009 Feb 12.

4.

Protective effect of topiramate on kainic acid-induced cell death in mice hippocampus.

Park HJ, Kim HJ, Park HJ, Ra J, Zheng LT, Yim SV, Chung JH.

Epilepsia. 2008 Jan;49(1):163-7. Epub 2007 Sep 12.

5.

Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures.

Rakhade SN, Zhou C, Aujla PK, Fishman R, Sucher NJ, Jensen FE.

J Neurosci. 2008 Aug 6;28(32):7979-90. doi: 10.1523/JNEUROSCI.1734-08.2008.

7.

AMPA receptor antagonist NBQX attenuates later-life epileptic seizures and autistic-like social deficits following neonatal seizures.

Lippman-Bell JJ, Rakhade SN, Klein PM, Obeid M, Jackson MC, Joseph A, Jensen FE.

Epilepsia. 2013 Nov;54(11):1922-32. doi: 10.1111/epi.12378. Epub 2013 Oct 1.

8.

NBQX blocks acute and late epileptogenic effects of perinatal hypoxia.

Jensen FE, Blume H, Alvarado S, Firkusny I, Geary C.

Epilepsia. 1995 Oct;36(10):966-72.

PMID:
7555960
9.

Kainic acid-induced seizures and brain damage in the rat: different effects of NMDA- and AMPA receptor antagonists.

Berg M, Bruhn T, Johansen FF, Diemer NH.

Pharmacol Toxicol. 1993 Nov;73(5):262-8.

PMID:
8115308
10.

Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures.

Sanchez RM, Koh S, Rio C, Wang C, Lamperti ED, Sharma D, Corfas G, Jensen FE.

J Neurosci. 2001 Oct 15;21(20):8154-63.

11.

Neuroprotective effects of NBQX on hypoxia-induced neuronal damage in rat hippocampus.

Matsuoka Y, Kitamura Y, Tsukahara T, Terai K, Tooyama I, Kimura H, Taniguchi T.

Neuroreport. 1995 Nov 13;6(16):2205-8.

PMID:
8595203
12.

Effects of topiramate on seizure susceptibility in kainate-kindled rats: involvement of peripheral-type benzodiazepine receptors.

Chen C, Lang S, Xu G, Liu X, Zuo P.

Seizure. 2008 Jun;17(4):358-63. doi: 10.1016/j.seizure.2007.11.021. Epub 2007 Dec 27.

13.

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

Shimizu-Sasamata M, Kawasaki-Yatsugi S, Okada M, Sakamoto S, Yatsugi S, Togami J, Hatanaka K, Ohmori J, Koshiya K, Usuda S, Murase K.

J Pharmacol Exp Ther. 1996 Jan;276(1):84-92.

PMID:
8558460
14.

Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.

Follett PL, Deng W, Dai W, Talos DM, Massillon LJ, Rosenberg PA, Volpe JJ, Jensen FE.

J Neurosci. 2004 May 5;24(18):4412-20.

15.
16.

Neuroprotective effect of topiramate on hypoxic ischemic brain injury in neonatal rats.

Noh MR, Kim SK, Sun W, Park SK, Choi HC, Lim JH, Kim IH, Kim HJ, Kim H, Eun BL.

Exp Neurol. 2006 Oct;201(2):470-8. Epub 2006 Aug 1.

PMID:
16884714
17.
18.
19.

The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

Chapman AG, Smith SE, Meldrum BS.

Epilepsy Res. 1991 Jul;9(2):92-6.

PMID:
1794356
20.

Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.

Brambrink AM, Martin LJ, Hanley DF, Becker KJ, Koehler RC, Traystman RJ.

J Cereb Blood Flow Metab. 1999 Aug;19(8):927-38.

Items per page

Supplemental Content

Write to the Help Desk